SUPPLY AGREEMENTSupply Agreement • December 18th, 2018 • Centogene B.V. • Services-medical laboratories
[*****] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission.
TO GLOBAL MASTER SERVICES AGREEMENT AND TO SUPPLY AGREEMENTGlobal Master Services Agreement and Supply Agreement • December 18th, 2018 • Centogene B.V. • Services-medical laboratories
This Amendment (“2017 Amendment”) to the Global Master Services Agreement dated 1 January 2015 (“MSA”) and the Supply Agreement dated 1 January 2016 (“Supply Agreement”) is entered into as of 3 May, 2017 (“2017 Amendment Effective Date”) by and between
Global Master Services AgreementGlobal Master Services Agreement • December 18th, 2018 • Centogene B.V. • Services-medical laboratories
[*****] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission.
TO GLOBAL MASTER SERVICES AGREEMENT AND TO SUPPLY AGREEMENTGlobal Master Services Agreement and Supply Agreement • December 18th, 2018 • Centogene B.V. • Services-medical laboratories
This Amendment (“2019 Amendment”) to the Global Master Services Agreement dated 1 January 2015 (“MSA”) and the Supply Agreement dated 1 January 2016 (“Supply Agreement”) is entered into as of 2 July, 2018 by and between
DEED OF ISSUE CENTOGENE N.V.Deed of Issue • December 18th, 2018 • Centogene B.V. • Services-medical laboratories
Centogene N.V., a public company with limited liability, having its corporate seat in Amsterdam (address: Am Strande 7, 18055 Rostock, Germany, trade register number: 72822872) (the “Company”).
